NHS England has announced that children will no longer be prescribed puberty blockers at gender identity clinics, except as part of clinical research trials. This significant policy shift follows an independent review and a dramatic increase in referrals to the Gender Identity Development Service (GIDS) - from under 250 to over 5,000 in a decade. Puberty blockers, used to pause physical puberty changes, have been at the centre of debate due to concerns about consent and long-term effects. The trust which runs GIDS will close at the end of March, replaced by two new services at Great Ormond Street and Alder Hey hospitals. These will offer a more holistic approach to care, including experts in neurodiversity, paediatrics, and mental health. Currently, fewer than 100 children are on puberty blockers and will continue their treatment. This decision has been described as a 'landmark' by health minister Maria Caulfield, who has emphasised child safety and evidence-based care. See also